Compare Abeona Therapeutics Inc (ABEO) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Ascendis Pharma A/S — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Ascendis Pharma A/S trades at $253.76 (market cap $16.67B). The key difference: Ascendis Pharma A/S is far larger — about 39.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| ABEO | ASND | |
|---|---|---|
Market Cap | $421.19M | $16.67B |
Sector | Health | Health |
52-Week High | $7.45 | $277.18 |
52-Week Low | $4.17 | $189.74 |
Enterprise Value | $276.10M | $17.04B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
